Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB

SETTING: The recommended dosing regimen for bedaquiline (BDQ), consisting of a 2-week loading phase (400 mg/day), followed by a maintenance phase (200 mg three times/week), might pose challenges when treatment is interrupted and needs to be reinitiated. Guidance on BDQ treatment re-initiation is, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kambili, C., Rossenu, S., Hoetelmans, R. M. W., Birmingham, E., Bakare, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272739/
https://www.ncbi.nlm.nih.gov/pubmed/35768912
http://dx.doi.org/10.5588/ijtld.21.0678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272739/
https://www.ncbi.nlm.nih.gov/pubmed/35768912
http://dx.doi.org/10.5588/ijtld.21.0678

Ejemplares similares